about
Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).Modulation of p-glycoprotein transport function at the blood-brain barrier.Convection-enhanced delivery of interleukin-13 receptor-directed cytotoxin for malignant glioma therapy.Temozolomide in newly diagnosed malignant gliomas: administered concomitantly with radiotherapy, and thereafter as consolidation treatment.
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
New strategy developments in brain tumor therapy.
@ast
New strategy developments in brain tumor therapy.
@en
New strategy developments in brain tumor therapy.
@nl
type
label
New strategy developments in brain tumor therapy.
@ast
New strategy developments in brain tumor therapy.
@en
New strategy developments in brain tumor therapy.
@nl
prefLabel
New strategy developments in brain tumor therapy.
@ast
New strategy developments in brain tumor therapy.
@en
New strategy developments in brain tumor therapy.
@nl
P356
P1476
New strategy developments in brain tumor therapy
@en
P2093
P304
P356
10.2174/1381612013397221
P577
2001-11-01T00:00:00Z